AZTR Azitra Inc
$0.18▼ -1.11%
Healthcare
Other
After hours
$0.18▲ +0.90%
Sep 11, 7:53 PM ET
Volume 287.9K
Avg Volume (10D) 706.9K
Key Metrics & Fundamentals
Market Cap
$10.79M
P/E Ratio
8.9
Div Yield
–%
52W Range
0.10 - 1.09
% vs 50 MA
21.32%
% vs 200 MA
-17.96%
RSI-14
61.8
MACD Histogram
+0.0000
Beta (1Y vs SPY)
-0.15
Free Cash Flow
-$3.41M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.23M
COGS
–
Operating Exp
$3.42M
Operating Income
-$3.42M
EBIT
-$3.42M
Pretax Income
-$3.35M
Net Income
-$3.35M
EPS (Diluted)
-0.17
Price & Volume History
Loading chart…
Recent News

Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire · Sep 8, 2026 12:00 PM

Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards
PR Newswire · Aug 21, 2026 12:00 PM

Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates
PR Newswire · Aug 12, 2026 9:00 PM
/C O R R E C T I O N -- Azitra, Inc./
PR Newswire · Jul 15, 2026 3:33 PM
Azitra, Inc. Announces Breakthough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased Distribution and Elasticity
PR Newswire · Jul 15, 2026 2:10 PM
Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond
PR Newswire · Jun 17, 2026 12:00 PM
Top Premarket Gainers
MT Newswires · Jun 17, 2026 11:08 AM
Azitra, Inc. to Present at 2026 BIO International Convention
PR Newswire · Jun 16, 2026 9:28 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See AZTR's money flow as a full page
Social Sentiment
Avg +0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.